Education
About Us
Working with TipRanks
Follow Us
Catheter Precision (VTAK)
:VTAK
VTAK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $4.75
Previous CloseN/A
Volume115.56K
Average Volume (3M)28.30M
Market Cap
$2.99M
Enterprise Value$3.93M
Total Cash (Recent Filing)$450.00K
Total Debt (Recent Filing)$1.69M
Price to Earnings (P/E)―
Beta1.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.53
Shares Outstanding12,593,873
10 Day Avg. Volume1,691,039
30 Day Avg. Volume28,299,483
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.41
Price to Sales (P/S)0.00
P/FCF Ratio-0.28
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue2.26
Enterprise Value/Gross Profit9.07
Enterprise Value/Ebitda-0.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Catheter Precision News
PremiumMarket News
3 Penny Stocks to Watch Now, 6/12/25
PremiumCompany Announcements
Catheter Precision’s LockeT Sales Surge in Q2 2025
Options Prices
Currently, No data available
---
Ownership Overview
8.31% Insiders
0.06% Mutual Funds
3.56% Other Institutional Investors
88.07% Public Companies and Individual Investors
VTAK FAQ
What was Catheter Precision’s price range in the past 12 months?
Catheter Precision lowest stock price was $0.16 and its highest was $4.75 in the past 12 months.
What is Catheter Precision’s market cap?
Catheter Precision’s market cap is $2.99M.
When is Catheter Precision’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Catheter Precision’s earnings last quarter?
Catheter Precision released its earnings results on Nov 13, 2024. The company reported -$2.01 earnings per share for the quarter, beating the consensus estimate of -$2.2 by $0.19.
Is Catheter Precision overvalued?
According to Wall Street analysts Catheter Precision’s price is currently Overvalued.
Does Catheter Precision pay dividends?
Catheter Precision does not currently pay dividends.
What is Catheter Precision’s EPS estimate?
Catheter Precision’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Catheter Precision have?
Catheter Precision has 12,593,873 shares outstanding.
What happened to Catheter Precision’s price movement after its last earnings report?
Catheter Precision reported an EPS of -$2.01 in its last earnings report, beating expectations of -$2.2. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Catheter Precision?
Currently, no hedge funds are holding shares in VTAK
Company Description
Catheter Precision
Catheter Precision (VTAK) is a medical technology company focused on developing innovative solutions for the treatment of cardiac arrhythmias. The company operates within the healthcare sector, specifically targeting electrophysiology. Catheter Precision's core products include advanced catheters and related technologies designed to enhance the accuracy and effectiveness of cardiac mapping and ablation procedures, ultimately improving patient outcomes.
Technical Analysis
Nuwellis
―
Sintx Technologies
―
ReShape Lifesciences
―
Vivos Therapeutics
―
Heart Test Laboratories, Inc.
―